WVA and ThermaMEDx Ink Partnership to Support Eye Care Professionals’ Fight Against Dry Eyes

By Carl Sweat | June 29, 2021

WVA and ThermaMEDx Ink Partnership to Support Eye Care Professionals’ Fight Against Dry Eyes New EverTears® Recognized as a “Game Changer” Therapy for Dry Eyes and Meibomian Gland Dysfunction (MGD) ATLANTA, GEORGIA, USA, June 29, 2021/EINPresswire.com/ — Medical device innovator ThermaMEDx, LLC today announced a sales and distribution partnership with WVA, one of the largest…

Read More

In-Office Heat Therapy Proven to Help Dry Eye Patients… EverTears® Delivers Heat Therapy For Home Use at a Fraction of the Cost

By Carl Sweat | June 26, 2021 |

Multiple clinical studies have demonstrated the effectiveness of in-office procedures performed with equipment from Johnson & Johnson (LipiFlow®), Alcon (iLux®) at addressing the root cause of Dry Eye Disease related to Meibomian Gland Dysfunction (MGD). The science is clear that controlled heat between 104°-108.5°F (40°-42.5°C) is effective in melting solidified meibum in the meibomian glands within…

Read More

Drs. Melton & Thomas Review EverTears® in “Clinical Perspectives On Patient Care”

By Carl Sweat | June 24, 2021

“EverTears stands in stark contrast to all other at-home, self-administered approaches, which typically require longer application times. It is always gratifying when new technologies raise the level of patient care. It is our impression that the new EverTears applicators do just this.” Drs. Ronald Melton and Randall ThomasReview of Optometry magazine June 2021 Full article…

Read More